ebook: The definitive guide to understanding protein stability
Learn how to measure protein stability, why it’s important, and what the key technologies are available to measure it.
List view / Grid view
Learn how to measure protein stability, why it’s important, and what the key technologies are available to measure it.
15 June 2020 | By Horizon Discovery
Watch our on-demand webinar with Horizon Discovery which summarises the challenges in translating promising pre-clinical therapeutic candidates into clinical success.
A result is only as good as the sample preparation that preceded it.
ESHG 2019: Automated sample preparation using magnetic bead technology and KingFisher instruments.
New opportunities for liquid biopsy: At automated workflow for isolating circulating tumor cells using KingFisher instruments.
Learn how fragment-based drug discovery improves hit rates and delivers higher-value targets using various biophysical methods.
Learn why researchers turned to biophysical methods to expose the molecular mechanisms of neurodegenerative diseases.
Learn practical tips from eight Principal Investigators about how to start your own lab.
Learn how you could use high-content analysis for functional & phenotypic assays in your infectious disease research or drug discovery.
7 May 2020 | By PerkinElmer
High-throughput screening (HTS) cascades have evolved to ensure that high quality hits can be identified from large screening collections.
A series of three new assays to screen for drug compounds or proteins that combat the COVID-19 coronavirus has been developed.
Researchers investigating telomere dieases such as dyskeratosis congenita have found lead compounds that reverse cellular ageing in mouse models of the condition.
Researchers have found a lead compound which they say inhibits SARS-CoV-2 viral replication and demonstrates good pharmacokinetic activity in vivo.
High-throughput screening of thousands of compounds has revealed several candidates, including lead compound ebselen, with the potential for treating COVID-19.
After screening 300 antibodies, Celltrion has identified the 14 most powerful that could potentially combat the COVID-19 coronavirus.